ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
about
The little elongation complex regulates small nuclear RNA transcriptionFB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activityThe little elongation complex functions at initiation and elongation phases of snRNA gene transcriptionThe interaction between EAP30 and ELL is modulated by MCM2ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELLU19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasiaU19/Eaf2 binds to and stabilizes von hippel-lindau protein.A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA transcription mediated by RNA polymerase II.Phosphorylation and the Cajal body: modification in search of function.Cajal bodies: where form meets function.Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.RBM10 Modulates Apoptosis and Influences TNF-α Gene Expression.Specific genomic cues regulate Cajal body assemblyBioinformatics Analysis and Validation of the Expressed Sequences Tag in Human Colorectal Adenocarcinoma.The 7SK snRNP associates with the little elongation complex to promote snRNA gene expression.Bioinformatics Analysis and Validation of the Expressed Sequences Tag in Human Colorectal Adenocarcinoma.
P2860
Q24300557-8373A92E-D645-4760-9892-2A0FA0159D1FQ24301280-9ABD1A94-D3F6-4FCB-B536-33D06A06EDFDQ24316411-BBDCDD0C-B080-40F9-A86E-ED6B802029D4Q24324047-FC7AE91A-1C13-4DF4-A255-3D1825933B4CQ24531614-CDB744B0-C75A-4D60-9192-44387B2D18E8Q28590029-D1EFD615-015C-4A7C-8865-7DC5EAD8FDCDQ33590977-70A7E83C-4F03-499F-A86C-EF3BD4243490Q37608722-3C218938-C365-483C-AA86-27A031BF4801Q37700947-2DC6BEB9-C3C0-4DF5-BEFF-23C3B5432D2EQ38050096-108DA608-2CFE-491F-8E5E-5ECECE22306EQ40219809-3647C6D2-E079-4C01-AEBE-0E013F655BDAQ40455878-B40D94F9-3F78-4811-8CE0-74A45599ADE9Q42335063-8217C435-863B-4690-A298-3CA777D6E723Q46858695-99616292-A9AA-42FC-8FB8-452895734E4FQ48170699-66AAB179-83EB-4DF4-9183-EFDAB2CD5E7BQ54220114-E355987C-5E56-42F4-B961-770A7852CDBD
P2860
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@ast
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@en
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@nl
type
label
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@ast
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@en
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@nl
prefLabel
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@ast
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@en
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@nl
P2093
P2860
P921
P356
P1476
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia
@en
P2093
Federico Simone
Joseph J Kaberlein
Michael J Thirman
Paul E Polak
Roger T Luo
P2860
P304
P356
10.1091/MBC.E02-07-0394
P407
P577
2003-04-01T00:00:00Z